The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Experimental Peptide Creates Risk for Athletes fda warning bpc 157 peptide products New Details 157 BPC 157: The peptide with big claims and scant evidence STAT of the Federal Food, Drug, and Cosmetic Act (FDCA).*